Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TNF Pharmaceuticals, Inc. - Common Stock (NQ:TNFA)

0.3662 +0.0062 (+1.72%)
Streaming Delayed Price Updated: 2:37 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 129,553
Open 0.3492
Bid (Size) 0.3625 (5)
Ask (Size) 0.3699 (2)
Prev. Close 0.3600
Today's Range 0.3379 - 0.3700
52wk Range 0.3250 - 2.160
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia
From TNF Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
-68.2%
-68.2%
1 Month
-12.4%
-12.4%
3 Month
-68.2%
-68.2%
6 Month
-77.4%
-77.4%
1 Year
-81.7%
-81.7%

More News

Read More
What's going on in today's after hours session
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025
From TNF Pharmaceuticals, Inc.
Via Business Wire
Stay updated with the stocks that are on the move in today's after-hours session.
Via Chartmill
TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor
From TNF Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
From TNF Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
From TNF Pharmaceuticals, Inc.
Via Business Wire
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
From TNF Pharmaceuticals, Inc.
Via Business Wire
TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
From TNF Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
From TNF Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline
From TNF Pharmaceuticals, Inc.
Via Business Wire
TNFA Stock Earnings: TNF Pharmaceuticals Reported Results for Q2 2024
Via InvestorPlace

Frequently Asked Questions

Is TNF Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, TNF Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does TNF Pharmaceuticals, Inc. - Common Stock trade on?
TNF Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TNF Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for TNF Pharmaceuticals, Inc. - Common Stock is TNFA on the Nasdaq Stock Market
What is the current price of TNF Pharmaceuticals, Inc. - Common Stock?
The current price of TNF Pharmaceuticals, Inc. - Common Stock is 0.3662
When was TNF Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of TNF Pharmaceuticals, Inc. - Common Stock was at 03/31/25 02:37 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.